Proctozone-B

openFDA label record#

This page contains supplementary openFDA label data. For the canonical label presentation, use the corresponding DailyMed Structured Product Label.

Verified complete openFDA source JSON (canonical bytes are SHA-256 checked before publication)

Brand name
Proctozone-B
Generic name
BISACODYL
Manufacturer
Rising Pharma Holdings, Inc.
Product type
HUMAN OTC DRUG
SPL set ID
8f4bad3d-16ce-469e-9c65-74a09fd0af1c
SPL ID
d5aaad18-797d-48cd-9ebb-2120207b742f
Version
1
Effective date
2026-09-18
Source export date
2026-11-13
Source partition
12
Source file
https://download.open.fda.gov/drug/label/drug-label-0012-of-0014.json.zip
Source object key
raw/openfda/drug-label/2026-11-13/df974ce21ba33b4471866e2af5412327fbd4bcd68d14b42d7cfb3aa15d163738/drug-label-0012-of-0014.json.zip
Source manifest SHA-256
8f2b6d063d44586cf97cedcdf1bdf9e261cc88632cc6855424b801bb206208d7
Import run
20261116T150851Z
Imported at
2026-11-16 17:54:39
Harmonized routes table
Harmonized routes
ORAL

Warnings cross-check#

openFDA text is shown for search and cross-checking; DailyMed SPL is canonical.

Warnings sections page 1 of 1 · 1 matching rows.

warnings

Warnings Do not use ● if you cannot swallow without chewing Ask a doctor before use if you have ● stomach pain, nausea or vomiting ● noticed a sudden change in bowel habits that lasts more than 2 weeks When using this product ● it may cause stomach discomfort, faintness and cramps ● do not chew or crush tablet(s) ● do not use within 1 hour after taking an antacid or milk Stop use and ask a doctor if ● you have rectal bleeding or fail to have a bowel movement after using this product. These could be signs of a serious condition. ● you need to use a laxative for more than 1 week If pregnant or b reast-feeding, ask a health professional before use. Keep out of reach of children. In case of overdose, get medical help or contact a Poison Control Center right away.

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.